Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05MJU
|
||||
Former ID |
DNC000072
|
||||
Drug Name |
4-iodobenzo[b]thiophene 2-carboxamidine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [534982] | ||
Structure |
Download2D MOL |
||||
Formula |
C9H8IN2S+
|
||||
Canonical SMILES |
C1=CC2=C(C=C(S2)C(=[NH2+])N)C(=C1)I
|
||||
InChI |
1S/C9H7IN2S/c10-6-2-1-3-7-5(6)4-8(13-7)9(11)12/h1-4H,(H3,11,12)/p+1
|
||||
InChIKey |
YERQOXAYAFWFEJ-UHFFFAOYSA-O
|
||||
CAS Number |
CAS 13922-04-8
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
SuperDrug ATC ID |
L01XX16
|
||||
SuperDrug CAS ID |
cas=000459869
|
||||
Target and Pathway | |||||
Target(s) | Urokinase-type plasminogen activator | Target Info | Inhibitor | [534982] | |
NetPath Pathway | IL2 Signaling Pathway | ||||
EGFR1 Signaling Pathway | |||||
Pathway Interaction Database | Beta1 integrin cell surface interactions | ||||
E2F transcription factor network | |||||
Beta3 integrin cell surface interactions | |||||
Osteopontin-mediated events | |||||
Validated transcriptional targets of AP1 family members Fra1 and Fra2 | |||||
amb2 Integrin signaling | |||||
ATF-2 transcription factor network | |||||
AP-1 transcription factor network | |||||
Beta2 integrin cell surface interactions | |||||
Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling | |||||
Beta5 beta6 beta7 and beta8 integrin cell surface interactions | |||||
FGF signaling pathway | |||||
Reactome | Dissolution of Fibrin Clot | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.